Corbus Pharmaceuticals's total assets for Q2 2025 were $125.08M, a decrease of -10.61% from the previous quarter. CRBP total liabilities were $14.09M for the fiscal quarter, a 9.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.